Outlook Therapeutics Inc. (OTLK)
NASDAQ: OTLK
· Real-Time Price · USD
0.89
0.00 (0.00%)
At close: Sep 04, 2025, 3:59 PM
0.89
0.19%
Pre-market: Sep 05, 2025, 09:08 AM EDT
0.00% (1D)
Bid | 0.87 |
Market Cap | 39.45M |
Revenue (ttm) | 1.68M |
Net Income (ttm) | -43.44M |
EPS (ttm) | -0.84 |
PE Ratio (ttm) | -1.06 |
Forward PE | -1.13 |
Analyst | Hold |
Ask | 0.92 |
Volume | 3,610,067 |
Avg. Volume (20D) | 2,988,680 |
Open | 0.92 |
Previous Close | 0.89 |
Day's Range | 0.82 - 0.92 |
52-Week Range | 0.79 - 8.32 |
Beta | 0.49 |
About OTLK
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OTLK
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OTLK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Outlook Therapeutics Inc. is scheduled to release its earnings on
Dec 26, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 days ago
-21.91%
Outlook Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
1 week ago
-54.2%
Outlook Therapeutics shares are trading lower after the FDA issued a Complete Response Letter for its resubmitted ONS-5010 BLA.